02.03.2015
- Bachem announced today the forthcoming acquisition of American Peptide Company (APC), based in California. The Japanese seller ILS, a wholly-owned subsidiary of Otsuka Chemical...
03.12.2014
- Bachem and GlyTech announced that they have entered into a co-promotion agreement for GlyTech's glycosylation technology. As part of the agreement, Bachem will leverage its sales...
08.08.2014
- Carbogen Amcis, Swiss-based pharmaceutical process development and active pharmaceutical ingredient (API) manufacturer, has announced plans to take over operations of a high...
05.06.2014
- Bachem is specialized in the process development and the manufacturing of peptides and complex organic molecules as active pharmaceutical ingredients (APIs), as well as innovative...
09.12.2009
- Bachem and Debiopharm announced the conclusion of a follow-up agreement for the long-term supply of Triptorelin Pamoate. Bachem has been supplying Triptorelin Pamoate, the active...
